(Q51691419)

9 April 2018

title

Reduced transforming growth factor-beta receptor II expression in hepatocellular carcinoma correlates with intrahepatic metastasis. (English)

1 reference

9 April 2018

main subject

hepatocellular carcinoma

1 reference

11

Michiie Sakamoto

1 reference

9 April 2018

author name string

Takao Mamiya

1

1 reference

9 April 2018

Ken Yamazaki

2

1 reference

9 April 2018

Yohei Masugi

3

1 reference

9 April 2018

Taisuke Mori

4

1 reference

9 April 2018

Kathryn Effendi

5

1 reference

9 April 2018

Wenlin Du

6

1 reference

9 April 2018

Taizo Hibi

7

1 reference

9 April 2018

Minoru Tanabe

8

1 reference

9 April 2018

Masakazu Ueda

9

1 reference

9 April 2018

Tadatoshi Takayama

10

1 reference

9 April 2018

publication date

7 June 2010

1 reference

9 April 2018

published in

Laboratory Investigation

1 reference

9 April 2018

volume

90

1 reference

9 April 2018

issue

9

1 reference

9 April 2018

page(s)

1339-1345

1 reference

9 April 2018

https://scigraph.springernature.com/pub.10.1038/labinvest.2010.105

exact match

0 references

cites work

Hepatocellular carcinoma: an epidemiologic view

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

TGFbeta signaling in growth control, cancer, and heritable disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

TGF-beta signaling in tumor suppression and cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Genetic changes in the transforming growth factor beta (TGF-beta) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Microsatellite instability and mutated type II transforming growth factor-beta receptor gene in gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Cluster analysis and display of genome-wide expression patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Cell motility mediated by rho and rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Altered expression of TGF-beta receptors in hepatocellular carcinoma--effects of a constitutively active TGF-beta type I receptor mutant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Promoter methylation of TGFbeta receptor I and mutation of TGFbeta receptor II are frequent events in MSI sporadic gastric carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Defective expression of transforming growth factor beta receptor type II is associated with CpG methylated promoter in primary non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Postoperative Recurrence of Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Overexpression of cortactin is involved in motility and metastasis of hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Inhibition of transforming growth factor beta receptor I kinase blocks hepatocellular carcinoma growth through neo-angiogenesis regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

Emergence of malignant lesions within an adenomatous hyperplastic nodule in a cirrhotic liver. Observations in five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

7 January 2021

Roles of TGF-beta in hepatic fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

7 January 2021

Inhibitory effect of transforming growth factor-beta on DNA synthesis of adult rat hepatocytes in primary culture

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

7 January 2021

Smad2 and Smad4 gene mutations in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

7 January 2021

E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

7 January 2021

Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

7 January 2021

Hepatic resection for hepatocellular carcinoma. Clinical features and long-term prognosis

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

7 January 2021

Do the tumor cells of hepatocellular carcinomas dislodge into the portal venous stream during hepatic resection?

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2010.105

7 January 2021

10.1038/LABINVEST.2010.105

Identifiers

DOI

1 reference

9 April 2018

1 reference

9 April 2018